Advertisement

Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 338, Issue 5, pp 589–599 | Cite as

Multiple electrophysiological actions of amiodarone on guinea pig heart

  • Masahiro Aomine
Article

Summary

The cellular electrophysiologic effects of acute exposure to amiodarone (AM) on guinea pig papillary muscle (PM) and Purkinje fibres (PF) were investigated by means of conventional microelectrode techniques. Superfusion with AM < 1.1 × 10−4 mol/l reduced the maximum rate of rise (\(\dot V\)max) of the action potential (AP) upstroke phase 0 of both PM and PF stimulated at 1 Hz, without changing resting membrane potential (RMP) or action potential duration (APD). AM > 1.1 × 10−4 mol/l decreased APD at all levels, accompanied by decreases in \(\dot V\)max and RMP. PF AP's were much more sensitive to AM than PM. In contrast, chronic exposure (20 mg/kg/day, 3/12 weeks) prolonged PM APD at all levels and decreased Vmax. In addition, acute exposure shifted steady state inactivation of Vmax by 4–7 mV to more negative potentials. The decrease of Vmax was frequency- and concentration-dependent. Halfmaximal inhibition (IC50) of Vmax by AM was affected by K+-induced membrane depolarization (in 4 mmol/1 K+,IC50 ≌ 2.3 x 10−4 mol/l; in 8 mmol/1 K+, IC50 ≌ 9 x 10−5 mol/1). Frequency-dependentinhibitionof closed Na+ channels by AM was demonstrated and AM increased the time constant for recovery from Na+ channel blockade. Depression of PF plateau by AM was similar to the effects of tetrodotoxin (TTX). Finally, AM depolarized RMP of PM exposed to low K+. The multiplicity of changes suggests that AM exerts inhibitory effects on a number of ionic current components, including at least fast Na+ current, slow inward current, TTX-sensitive plateau and outward K+ currents. Possible implications with respect to the broad spectrum of antiarrhythmic activity exhibited by AM are considered.

Key words

Amiodarone Acute and chronic effects Guinea pig heart Anti-arrhythmic agent Cellular electrophysiology 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aomine M (1988a) Inhibition by amiodarone of slow response action potentials and contraction in guinea pig ventricular muscle. Gen Pharmacol 19:621–623CrossRefGoogle Scholar
  2. Aomine M (1988b) Effects of amiodarone on barium-induced automatic activity in guinea pig ventricular muscle. Gen Pharmacol 19 (in press)Google Scholar
  3. Aomine M, McCullough J, Mayuga R, Morrone W, Singer D (1984) Cellular electrophysiologic effects of acute exposure to amiodarone on guinea pig heart (abstr). Fed Proc 43:961Google Scholar
  4. Aomine M, McCullough J, Morrone W, Cigan A, Singer D (1985) Inhibition by amiodarone of steady-state Na current and slow inward current in guinea pig heart (abstr). Fed Proc 44:900Google Scholar
  5. Bean BP, Cohen CJ, Tsien RW (1983) Lidocaine block of sodium channels. J Gen Physiol 81:613–642CrossRefGoogle Scholar
  6. Corabceuf E, Deroubaix E, Coulombe A (1979) Effect of tetrodotoxin on action potentials of the conducting system in dog heart. Am J Physiol 236:H561-H567Google Scholar
  7. Davis LD, Temte JV (1969) Electrophysiological actions of lidocaine on canine ventricular muscle and Purkinje fibers. Circ Res 24:639–655CrossRefGoogle Scholar
  8. Follmer CH, Aomine M, Yeh JZ, Singer DH (1985) Amiodarone-induced block of Na current in isolated single canine Purkinje cells (abstr). Circulation 72 (Suppl):230Google Scholar
  9. Follmer CH, Aomine M, Yeh JZ, Singer DH (1987) Amiodarone-induced block of sodium current in isolated cardiac cells. J Pharmacol Exp Ther 243:187–196PubMedGoogle Scholar
  10. Fozzard HA, January CT, Makielski JC (1985) New studies of the excitatory sodium currents in heart muscle. Circ Res 56:475–485CrossRefGoogle Scholar
  11. Gettes LS, Reuter H (1974) Slow recovery from inactivation of inward currents in mammalian myocardial fibres. J Physiol 240:703–724CrossRefGoogle Scholar
  12. Goupil N, Lenfant J (1976) The effects of amiodarone on the sinus node activity of the rabbit heart. Eur J Pharmacol 39:23–31CrossRefGoogle Scholar
  13. Grant AO, Hondeghem LM, Katzung BG (1978) Effects of droperidol on depolarization-induced automaticity, maximum upstroke velocity (\(\dot V\) max) and the kinetics of recovery of V max in guinea-pig ventricular myocardium. J Pharmacol Exp Ther 205:193–203PubMedGoogle Scholar
  14. Heger JJ, Prystowsky EN, Jackman WM, Naccarelli GV, Warfel KA, Rinkenberger RL, Zipes DP (1981) Amiodarone: clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med 305:539–545CrossRefGoogle Scholar
  15. Heistracher P (1971) Mechanism of action of antifibrillatory drugs. Naunyn-Schmiedeberg's Arch Pharmacol 269:199–212CrossRefGoogle Scholar
  16. Hille B (1977) Local anesthetics: hydrophylic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol 69:497–515CrossRefGoogle Scholar
  17. Hoffman BF (1958) The action of quinidine and procainamide on single fiber of dog ventricle and specialized conducting system. An Acad Bras Cienc 29:365–368Google Scholar
  18. Hondeghem LM, Katzung BG (1977) Time- and voltage-dependent interaction of antiarrhythmic drugs with cardiac sodium channels. Biochem Biophys Acta 472:373–398PubMedGoogle Scholar
  19. Hondeghem LM, Katzung BG (1984) Antiarrhythmic agents: The modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Ann Rev Pharmacol Toxicol 24:387–423CrossRefGoogle Scholar
  20. Ikeda N, Nademanee K, Karman R, Singh BN (1984) Electrophysiologic effects of amiodarone: Experimental and clinical observation relative to serum and tissue drug concentrations. Am Heart J 108:890–898CrossRefGoogle Scholar
  21. Inoue D, Pappano AJ (1983) l-Palmitylcarnitine and calcium ions act similarly on excitatory ionic currents in avian ventricular muscle. Circ Res 52:625–634CrossRefGoogle Scholar
  22. Jochem G, Nawrath H (1983) Adenosine activates a potassium conductance in guinea-pig atrial heart muscle. Experientia 39:1347–1349CrossRefGoogle Scholar
  23. Josephson I, Sperelakis N (1976) Local anesthetic blockade of Ca2+-mediated action potentials in cardiac muscle. Eur J Pharmacol 40:201–208CrossRefGoogle Scholar
  24. Kadoya M, Konishi T, Tamamura T, Ikeguchi S, Hashimoto S, Kawai C (1985) Electrophysiological effects of amiodarone on isolated rabbit heart muscles. J Cardiovasc Pharmacol 7:643–648CrossRefGoogle Scholar
  25. Kodama I, Wilde A, Janse MI, Durrer D, Yamada K (1984) Combined effects of hypoxia, hyperkalemia and acidosis on membrane action potential and excitability of guinea pig ventricular muscle. J Mol Cell Cardiol 16:247–259CrossRefGoogle Scholar
  26. Mason JW, Hondeghem LM, Katzung BG (1983) Amiodarone blocks inactivated cardiac sodium channels. Pflügers Arch 396:79–81CrossRefGoogle Scholar
  27. Mason JW, Hondeghem LM, Katzung BG (1984) Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res 55:277–285CrossRefGoogle Scholar
  28. McGovern B, Garan H, Malacoff RE, DiMarco JP, Grant G, Sellers TD, Ruskin JN (1984) Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone. Am J Cardiol 53:1558–1563CrossRefGoogle Scholar
  29. Mentrard D, Vassort G, Clapier RV (1984) Effects of antiarrhythmic agents on the Ca conductance and the Na—Ca exchange in frog heart cells. J Physiol 353:76PGoogle Scholar
  30. Nademanee K, Hendrickson JA, Kannan R, Singh B (1982) Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: Potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia. Am Heart J 103:950–959CrossRefGoogle Scholar
  31. Nawrath H (1981) Action potential, membrane currents and force of contraction in mammalian heart muscle fibers treated with quinidine. J Pharmacol Exp Ther 216:176–182PubMedGoogle Scholar
  32. Neliat G, Moreau M, Ducouret P, Gargouil YM (1982a) Electrophysiological effects of butoprozine on isolated heart preparations. Comparison with amiodarone and verapamil. Arch Int Pharmacodyn 255:220–236PubMedGoogle Scholar
  33. Neliat G, Ducouret P, Moreau M, Gargouil YM (1982b) Effects of butoprozine on ionic currents in frog atrial and ferret ventricular fibres. Comparison with amiodarone and verapamil. Arch Int Pharmacodyn 255:237–255PubMedGoogle Scholar
  34. Nishimura M, Follmer CH, Cigan A, Yeh JZ, Singer D (1986) Amiodarone blocks Ca2+ current in guinea pig ventricular myocytes (abstr). Circulation 74:II-169Google Scholar
  35. Noble D (1965) Electrical properties of cardiac muscle attributable to inward going (anomalous) rectification. J Cell Comp Physiol 66:127–136CrossRefGoogle Scholar
  36. Northover BJ (1984) Alterations to the electrical activity of atrial muscle isolated from the rat heart, produced by exposure in vitro to amiodarone. Br J Pharmacol 82:191–197CrossRefGoogle Scholar
  37. Revenko SV, Khodorov BI, Aurutskii MY (1980) Blocking of inactivated sodium channels by the antiarrhythmic Cordarone. M Y Byull Eksper Biol Med 89:702–704Google Scholar
  38. Rosen MR, Gelband H, Hoffman BF (1972) Canine electrocardiographic and cardiac electrophysiologic changes induced by procainamide. Circulation 46:528–536CrossRefGoogle Scholar
  39. Rosen MR, Wit AL (1983) Electropharmacology of antiarrhythmic drugs. Am Heart J 106:829–839CrossRefGoogle Scholar
  40. Rosenbaum MB, Chiale PA, Halpern MS, Nau GJ, Przybylski J, Levi RJ, Lazzari JO, Elizari MV (1976) Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol 38:934–944CrossRefGoogle Scholar
  41. Rosenbaum MB, Chiale PA, Ryba D, Elizari MV (1974) Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Am J Cardiol 34:215–223CrossRefGoogle Scholar
  42. Sada H, Kojima M, Ban T (1979) Effect of procainamide on transmembrane action potentials in guinea-pig papillary muscles as affected by external potassium concentration. Naunyn-Schmiedeberg's Arch Pharmacol 309:179–190CrossRefGoogle Scholar
  43. Singer DH, Ten Eick RE (1969) Pharmacology of cardiac arrhythmias. Progr Cardiovasc Dis 11:488–514CrossRefGoogle Scholar
  44. Singh BN (1983) Amiodarone: Historical development and pharmacologic profile. Am Heart J 106:788–797CrossRefGoogle Scholar
  45. Singh BN, Vaughan Williams EM (1970) The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol 39:657–667CrossRefGoogle Scholar
  46. Varro A, Nakaya Y, Elharrar V, Surawicz B (1985) Use-dependent effects of amiodarone on V max in cardiac Purkinje fibers and ventricular muscle fibers. Eur J Pharmacol 112:419–422CrossRefGoogle Scholar
  47. Weidmann S (1956) Elektrophysiologie der Herzmuskelfaser. Hans Huber, BernGoogle Scholar
  48. Yabek SM, Kato R, Singh BN (1985) Acute effects of amiodarone on the electrophysiologic properties of isolated neonatal and adult cardiac fibers. J Am Coll Cardiol 5:1109–1115CrossRefGoogle Scholar
  49. Yabek SM, Kato R, Singh BN (1986) Effects of amiodarone and its metabolite, desethylamiodarone, on the electrophysiologic properties of isolated cardiac muscle. J Cardiovasc Pharmacol 8:197–207CrossRefGoogle Scholar
  50. Zipes DP, Bailey JC, Elharrar V (eds) (1980) The slow inward current and cardiac arrhythmias. Martinus Nijhoff, The Hague Boston LondonGoogle Scholar
  51. Zipes DP, Prystowsky EN, Heger JJ (1984) Amiodarone: Electrophysiologic actions, pharmacokinetics and clinical effects. J Am Coll Cardiol 3:1059–1071CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • Masahiro Aomine
    • 1
  1. 1.Department of PhysiologyMedical College of OitaOitaJapan

Personalised recommendations